Bottom line
How much do SHSSX and DLHIX overlap?
44% of their top holdings overlap by weight. 12 securities appear in both funds' top 25, making up 45.5% of SHSSX's assets and 39.0% of DLHIX's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings SHSSX and DLHIX have in common
| Holding | % of SHSSX | % of DLHIX | Overlap |
|---|---|---|---|
| Eli Lilly & Company LLY | 12.29% | 4.16% | 4.16% |
| Unitedhealth Group Inc UNH | 6.10% | 3.88% | 3.88% |
| Merck & Company Inc MRK | 4.94% | 3.68% | 3.68% |
| Gilead Sciences Inc GILD | 4.19% | 3.54% | 3.54% |
| Abbvie Inc ABBV | 3.94% | 4.19% | 3.94% |
| Amgen Inc AMGN | 3.37% | 2.27% | 2.27% |
| Vertex Pharmaceuticals Inc VRTX | 2.74% | 1.66% | 1.66% |
| Pfizer Inc PFE | 2.61% | 3.84% | 2.61% |
| Boston Scientific Corp BSX | 1.59% | 1.42% | 1.42% |
| Elevance Health Inc ELV | 1.56% | 3.25% | 1.56% |
| Astrazeneca Plc AZN | 1.21% | 3.27% | 1.21% |
| Regeneron Pharmaceuticals Inc REGN | 0.91% | 3.91% | 0.91% |
Source: SEC Form N-PORT (periods May 29, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in SHSSX
- Johnson & Johnson — 8.77%
- Thermo Fisher Scientific Inc — 3.02%
- Edwards Lifesciences Corp — 2.51%
- Danaher Corp — 2.00%
- Abbott Laboratories — 1.97%
- Intuitive Surgical Inc — 1.95%
- Teva Pharmaceutical Industries Ltd — 1.87%
- Argenx Se — 1.26%
- Biogen Inc — 1.21%
- Stryker Corp — 1.15%
- Blackrock Funds III — 1.01%
- Revolution Medicines Inc — 0.96%
- Humana Inc — 0.92%
Only in DLHIX
- Ucb Sa — 5.19%
- Roche Holding Ag — 3.01%
- Chugai Pharmaceutical Co Ltd — 2.77%
- Viatris Inc — 2.48%
- Oruka Therapeutics Inc — 2.41%
- Halozyme Therapeutics Inc — 2.30%
- Illumina Inc — 2.11%
- Alkermes Plc — 1.82%
- Viking Therapeutics Inc — 1.72%
- Roivant Sciences Ltd — 1.60%
- Neurocrine Biosciences Inc — 1.57%
- Arcus Biosciences Inc — 1.56%
- Zimmer Biomet Holdings Inc — 1.42%
Asset mix
| Asset type | SHSSX | DLHIX |
|---|---|---|
| Stocks | 99.8% | 94.8% |
| Preferred stock | — | 3.0% |
| Cash & short-term funds | 1.4% | 2.0% |
Source: SEC Form N-PORT (periods May 29, 2026 / Jun 30, 2026)
Country mix
| Country | SHSSX | DLHIX |
|---|---|---|
| US | 93.9% | 75.4% |
| BE | 0.3% | 5.2% |
| GB | 1.4% | 3.3% |
| IE | — | 3.2% |
| CH | 1.4% | 3.0% |
| JP | 0.2% | 2.8% |
| FR | — | 2.0% |
| IL | 1.9% | 0.3% |
Source: SEC Form N-PORT (periods May 29, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do SHSSX and DLHIX overlap?
What stocks do SHSSX and DLHIX have in common?
Should I own both SHSSX and DLHIX?
Which holds more stocks, SHSSX or DLHIX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.